SMILES string
C=CC(NC1=CC=CC=C1C2=CC=C(NC(CC3=CC=C(S(=O)(CC)=O)C=C3)=O)C=C2Cl)=O
assay
≥95% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
Cell penetrant, highly potent, selective, and non-toxic RORγ covalent inhibitor.
W6134 is a highly potent, selective RORγ (retinoic acid receptor-related orphan receptor γ) armed with a cell-permeable acrylamide warhead, which specifically targets RORγ (IC50 = 210 nM in HEK293Tcells co-transfected with Gal4-RORγ-LBD) by covalently modifying RORγ-Cys320 thiol while showing minimal activity against other nuclear receptors such as RORα, RXRγ, and ERRγ (IC50 > 20 μM). W6134 is effective in inducing apoptosis in C4-2B and 22Rv1 cell lines and reduces RORγ-mediated transcription, leading to decreased androgen receptor (AR) expression in a dose- and time-dependent manner. When tested in vivo (T1/2 = 21.3 min in mouse liver microsomes), W6134 significantly suppresses tumor growth in castration-resistant prostate cancers (CRPC) xenograft mouse models (5 or 10 mg/kg, i.p.) demonstrating its efficacy and safety.
W6134 is a highly potent, selective RORγ (retinoic acid receptor-related orphan receptor γ) armed with a cell-permeable acrylamide warhead, which specifically targets RORγ (IC50 = 210 nM in HEK293Tcells co-transfected with Gal4-RORγ-LBD) by covalently modifying RORγ-Cys320 thiol while showing minimal activity against other nuclear receptors such as RORα, RXRγ, and ERRγ (IC50 > 20 μM). W6134 is effective in inducing apoptosis in C4-2B and 22Rv1 cell lines and reduces RORγ-mediated transcription, leading to decreased androgen receptor (AR) expression in a dose- and time-dependent manner. When tested in vivo (T1/2 = 21.3 min in mouse liver microsomes), W6134 significantly suppresses tumor growth in castration-resistant prostate cancers (CRPC) xenograft mouse models (5 or 10 mg/kg, i.p.) demonstrating its efficacy and safety.
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持